Halozyme submits Enhanze SC NDA

HTI submitted an NDA to FDA for its Enhanze SC spreading agent to enhance the delivery of local anesthesia and contrast agents, and for subcutaneous fluid replacement (hypodermoclysis). Baxter (BAX) h...